{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-147017","form_type":"8-K","ticker":"PHAT","cik":"0001783183","company_name":"Phathom Pharmaceuticals, Inc.","filed_at":"2024-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.080084+00:00","generated_at":"2026-06-01T08:47:40.332890+00:00","sec_items":["5.07","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Phathom stockholders elect three Class II directors; ratify E&Y as auditor","bullets":["Elected Cola (24.1M for), Karbe (25.0M for), Parikh (21.3M for) with 10.8M broker non-votes each.","Ratified Ernst & Young as independent auditor for fiscal 2024: 37.9M for, 124.6K against, 1.1K abstain.","New non-employee directors get initial grant of 21,000 RSUs and options to purchase 35,000 shares.","Annual director equity grant set at 10,500 RSUs and options for 17,500 shares; cash retainers unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-147017","json":"https://secwatch.observer/filing/0001193125-24-147017.json","markdown":"https://secwatch.observer/filing/0001193125-24-147017.md","text":"https://secwatch.observer/filing/0001193125-24-147017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783183/000119312524147017/0001193125-24-147017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783183/000119312524147017/d810940d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:47:40.332890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}